Search Results - "ILJIN, Kristiina"

Refine Results
  1. 1
  2. 2

    FZD4 as a Mediator of ERG Oncogene―Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells by GUPTA, Santosh, ILJIN, Kristiina, SARA, Henri, MPINDI, John Patrick, MIRTTI, Tuomas, VAINIO, Paula, RANTALA, Juha, ALANEN, Kalle, NEES, Matthias, KALLIONIEMI, Olli

    Published in Cancer research (Chicago, Ill.) (01-09-2010)
    “…TMPRSS2-ERG and other gene fusions involving ETS factors and genes with strong promoter elements are common in prostate cancer. Although ERG activation has…”
    Get full text
    Journal Article
  3. 3

    Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells by Ketola, Kirsi, Vainio, Paula, Fey, Vidal, Kallioniemi, Olli, Iljin, Kristiina

    Published in Molecular cancer therapeutics (01-12-2010)
    “…Current treatment options for advanced and hormone refractory prostate cancer are limited and responses to commonly used androgen pathway inhibitors are often…”
    Get full text
    Journal Article
  4. 4

    Function of ERBB4 is determined by alternative splicing by Veikkolainen, Ville, Vaparanta, Katri, Halkilahti, Kalle, Iljin, Kristiina, Sundvall, Maria, Elenius, Klaus

    Published in Cell cycle (Georgetown, Tex.) (15-08-2011)
    “…Alternative splicing is a central tool of evolution that significantly increases the size of transcriptomes and generates functional specification. Within the…”
    Get full text
    Journal Article
  5. 5

    Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells by Ketola, Kirsi, Kallioniemi, Olli, Iljin, Kristiina

    Published in PloS one (12-12-2012)
    “…Current treatment options for castration- and treatment-resistant prostate cancer are limited and novel approaches are desperately needed. Our recent results…”
    Get full text
    Journal Article
  6. 6

    High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth by IIJIN, Kristiina, KETOLA, Kirsi, VAINIO, Paula, HALONEN, Pasi, KOHONEN, Pekka, FEY, Vidal, GRAFSTRÖM, Roland C, PERÄLÄ, Merja, KALLIONIEMI, Olli

    Published in Clinical cancer research (01-10-2009)
    “…Purpose: To identify novel therapeutic opportunities for patients with prostate cancer, we applied high-throughput screening to systematically explore most…”
    Get full text
    Journal Article
  7. 7

    High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion by Lehtinen, Laura, Ketola, Kirsi, Mäkelä, Rami, Mpindi, John-Patrick, Viitala, Miro, Kallioniemi, Olli, Iljin, Kristiina

    Published in Oncotarget (01-01-2013)
    “…Vimentin is an intermediate filament protein, with a key role in the epithelial to mesenchymal transition as well as cell invasion, and it is often upregulated…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Robust Approach for Quantifying Glucocorticoid Binding to the Anti-Cortisol Fab Fragment via Native Mass Spectrometry by Eronen, Veikko, Iljin, Kristiina, Pääkkönen, Johan, Jänis, Janne, Rouvinen, Juha, Nevanen, Tarja K., Hakulinen, Nina

    Published in ACS omega (16-04-2024)
    “…In the development of proteins, aptamers, and molecular imprints for diagnostic purposes, a major goal is to obtain a molecule with both a high binding…”
    Get full text
    Journal Article
  11. 11

    High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer by Vainio, Paula, Mpindi, John-Patrick, Kohonen, Pekka, Fey, Vidal, Mirtti, Tuomas, Alanen, Kalle A, Perälä, Merja, Kallioniemi, Olli, Iljin, Kristiina

    Published in PloS one (28-06-2012)
    “…Prostate cancer is a heterogeneous group of diseases and there is a need for more efficient and targeted methods of treatment. In this study, the potential of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker by Lehtinen, Laura, Vesterkvist, Pia, Roering, Pia, Korpela, Taina, Hattara, Liisa, Kaipio, Katja, Mpindi, John-Patrick, Hynninen, Johanna, Auranen, Annika, Davidson, Ben, Haglund, Caj, Iljin, Kristiina, Grenman, Seija, Siitari, Harri, Carpen, Olli

    Published in PloS one (16-03-2016)
    “…Preoperative diagnostics of ovarian neoplasms rely on ultrasound imaging and the serum biomarkers CA125 and HE4. However, these markers may be elevated in…”
    Get full text
    Journal Article
  14. 14

    FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion by Gardberg, Maria, Kaipio, Katja, Lehtinen, Laura, Mikkonen, Piia, Heuser, Vanina D, Talvinen, Kati, Iljin, Kristiina, Kampf, Caroline, Uhlen, Mathias, Grénman, Reidar, Koivisto, Mari, Carpén, Olli

    Published in PloS one (26-09-2013)
    “…Cancer cells can obtain their ability to invade and metastasise by undergoing epithelial-to-mesenchymal transition (EMT). Exploiting this mechanism of cellular…”
    Get full text
    Journal Article
  15. 15

    Characterization of Leukocyte Formin FMNL1 Expression in Human Tissues by Gardberg, Maria, Heuser, Vanina D., Iljin, Kristiina, Kampf, Caroline, Uhlen, Mathias, Carpén, Olli

    “…Formins are cytoskeleton regulating proteins characterized by a common FH2 structural domain. As key players in the assembly of actin filaments, formins direct…”
    Get full text
    Journal Article
  16. 16

    Tie receptors: new modulators of angiogenic and lymphangiogenic responses by Alitalo, Kari, Jones, Nina, Iljin, Kristiina, Dumont, Daniel J

    Published in Nature reviews. Molecular cell biology (01-04-2001)
    “…Angiogenesis is required for normal embryonic vascular development and aberrant angiogenesis contributes to several diseases, including cancer, diabetes and…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma by Nordberg, Janne, Mpindi, John Patrick, Iljin, Kristiina, Pulliainen, Arto Tapio, Kallajoki, Markku, Kallioniemi, Olli, Elenius, Klaus, Elenius, Varpu

    Published in PloS one (05-12-2012)
    “…Pediatric sarcomas, including rhabdomyosarcomas, Ewing's sarcoma, and osteosarcoma, are aggressive tumors with poor survival rates. To overcome problems…”
    Get full text
    Journal Article
  20. 20

    GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets by Mpindi, John Patrick, Sara, Henri, Haapa-Paananen, Saija, Kilpinen, Sami, Pisto, Tommi, Bucher, Elmar, Ojala, Kalle, Iljin, Kristiina, Vainio, Paula, Björkman, Mari, Gupta, Santosh, Kohonen, Pekka, Nees, Matthias, Kallioniemi, Olli

    Published in PloS one (18-02-2011)
    “…Meta-analysis of gene expression microarray datasets presents significant challenges for statistical analysis. We developed and validated a new bioinformatic…”
    Get full text
    Journal Article